1. Home
  2. RFL vs LOAN Comparison

RFL vs LOAN Comparison

Compare RFL & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • LOAN
  • Stock Information
  • Founded
  • RFL 2017
  • LOAN 1989
  • Country
  • RFL United States
  • LOAN United States
  • Employees
  • RFL N/A
  • LOAN N/A
  • Industry
  • RFL Real Estate
  • LOAN Real Estate Investment Trusts
  • Sector
  • RFL Finance
  • LOAN Real Estate
  • Exchange
  • RFL Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • RFL 55.3M
  • LOAN 61.4M
  • IPO Year
  • RFL N/A
  • LOAN 1999
  • Fundamental
  • Price
  • RFL $1.84
  • LOAN $5.59
  • Analyst Decision
  • RFL
  • LOAN
  • Analyst Count
  • RFL 0
  • LOAN 0
  • Target Price
  • RFL N/A
  • LOAN N/A
  • AVG Volume (30 Days)
  • RFL 25.8K
  • LOAN 17.9K
  • Earning Date
  • RFL 12-27-2024
  • LOAN 10-23-2024
  • Dividend Yield
  • RFL N/A
  • LOAN 8.26%
  • EPS Growth
  • RFL N/A
  • LOAN 6.53
  • EPS
  • RFL N/A
  • LOAN 0.49
  • Revenue
  • RFL $697,000.00
  • LOAN $7,394,068.00
  • Revenue This Year
  • RFL N/A
  • LOAN N/A
  • Revenue Next Year
  • RFL N/A
  • LOAN N/A
  • P/E Ratio
  • RFL N/A
  • LOAN $11.37
  • Revenue Growth
  • RFL 151.62
  • LOAN 5.79
  • 52 Week Low
  • RFL $1.29
  • LOAN $4.60
  • 52 Week High
  • RFL $2.50
  • LOAN $5.90
  • Technical
  • Relative Strength Index (RSI)
  • RFL 45.87
  • LOAN 67.44
  • Support Level
  • RFL $1.74
  • LOAN $5.55
  • Resistance Level
  • RFL $1.92
  • LOAN $5.75
  • Average True Range (ATR)
  • RFL 0.09
  • LOAN 0.09
  • MACD
  • RFL -0.00
  • LOAN 0.02
  • Stochastic Oscillator
  • RFL 40.91
  • LOAN 83.22

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: